Late-onset neutropenia following rituximab.
McLaughlin
Peter
P
Univertsity of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. pmclaugh@mail.mdanderson.org
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D006801:Humans; D007107:Immune System; D007938:Leukemia / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced*; D000069283:Rituximab; D013997:Time Factors
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab